tadalafil has been researched along with Pregnancy in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (53.57) | 24.3611 |
| 2020's | 13 (46.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Kawamura, T; Tachibana, R; Takakura, S; Takeuchi, H; Tanaka, H; Tanaka, K; Yoshikawa, K | 1 |
| Deprest, J; Kumar, S; Mol, BW; Russo, F; Turner, JM | 1 |
| Enomoto, N; Ikeda, T; Katsuragi, S; Maki, S; Takakura, S; Tanaka, H; Tanaka, K | 1 |
| Asghari, A; Hassanpour, S; Imani, MH; Khaksar, E | 1 |
| Aoki, S; Aoki, Y; Endo, M; Ikeda, T; Kasai, M; Kawamura, H; Kikuchi, N; Kinjo, T; Kotani, T; Kotera, M; Maegawa, Y; Maki, S; Nagao, K; Nakamura, K; Nakata, M; Nii, M; Nishimura, Y; Ogura, T; Sekizawa, A; Suga, S; Takakura, S; Takano, M; Tamaru, S; Tanaka, H; Tanaka, K; Tanaka, Y; Ushida, T; Yasuhi, I; Yasui, O; Yoshida, Y | 1 |
| Enomoto, N; Hirayama, M; Ikeda, T; Kitamura, A; Kondo, E; Magawa, S; Maki, S; Nii, M; Okamoto, K; Sawada, H; Takakura, S; Tanaka, H; Tanaka, K; Tsuji, M; Yodoya, N | 1 |
| Baker, PN; Ganzevoort, W; Gluud, C; Groom, KM; Jakobsen, JC; Kariya, CT; Kenny, LC; Leemhuis, AG; Magee, LA; Mol, BWJ; Papageorghiou, AT; Pels, A; Sharp, AN; von Dadelszen, P | 1 |
| Hashizume, Y; Ikeda, T; Sato, E; Sato, H; Sekimoto, A; Takahashi, N; Tanaka, K | 1 |
| Endoh, M; Furuhashi, F; Ikeda, T; Kaneda, MK; Kimura, T; Kotani, T; Magawa, S; Maki, S; Nii, M; Nishimura, Y; Ogura, T; Sekizawa, A; Tanaka, H; Tanaka, K; Tsuji, M | 1 |
| Cai, W; Chen, S; Li, Y; Niu, X; Wang, B; Yang, N | 1 |
| Enomoto, N; Ikeda, T; Katsuragi, S; Maki, S; Nii, M; Takakura, S; Tanaka, H; Tanaka, K; Toriyabe, K; Tsuchiya, K | 1 |
| Ikeda, T; Katsuragi, S; Kawamura, T; Maki, S; Tachibana, R; Takeuchi, H; Tanaka, H; Tanaka, K; Toriyabe, K; Yoshikawa, K | 1 |
| Ikeda, T; Kubo, M; Maki, S; Nii, M; Tanaka, H; Umekawa, T | 1 |
| Aggarwal, S; Ambalavanan, N; Bradley, WE; Carlisle, MA; Dell'Italia, L; Doran, S; Ford, DA; Jilling, T; Lam, A; Lambert, JA; Matalon, S; Patel, RP; Ren, C | 1 |
| Ikeda, T; Kamimoto, Y; Kondo, E; Kubo, M; Maki, S; Murabayashi, N; Nii, M; Osato, K; Tanaka, H; Umekawa, T | 1 |
| Hosoda, H; Ikeda, T; Ikemura, K; Kamimoto, Y; Katayama, K; Kondo, E; Kubo, M; Ma, N; Maki, S; Miyoshi, T; Nii, M; Okuda, M; Osato, K; Tanaka, H; Tanaka, K; Umekawa, T; Yoshida, T; Yoshikawa, K | 1 |
| Hatano, F; Ikeda, T; Kamimoto, Y; Kubo, M; Magawa, S; Maki, S; Nii, M; Osato, K; Tanaka, H; Tanaka, K; Tsuji, M; Umekawa, T | 1 |
| Estrada, SM; Ieronimakis, N; Napolitano, PG; Reed, LC; Schmiedecke, SS; Villazana-Kretzer, DL; Walton, RB | 1 |
| Endoh, M; Ikeda, T; Kamimoto, Y; Kimura, T; Kodera, M; Kotani, T; Kubo, M; Maki, S; Minamide, C; Nakamura, M; Nii, M; Nishikawa, M; Nishimura, Y; Ogura, T; Osato, K; Sekizawa, A; Tamaru, S; Tanaka, H; Tanaka, K; Umekawa, T | 1 |
| Endoh, M; Furuhashi, F; Hosoda, H; Ikeda, T; Ikemura, K; Kamimoto, Y; Kaneda, MK; Kato, I; Kimura, T; Kondo, E; Ma, N; Magawa, S; Maki, S; Miyoshi, T; Nii, M; Okuda, M; Owa, T; Shimada, K; Tachibana, R; Tanaka, H; Tanaka, K; Tsuji, M; Umekawa, T; Yoshikawa, K | 1 |
| Artigiane-Neto, R; Fujiki, RTM; Martins, JL; Mismetti, MM; Montero, EFS; Souza, CM; Souza, CVCP; Teixeira, LC | 1 |
| Furuhashi, F; Ikeda, T; Kondo, E; Kubo, M; Magawa, S; Maki, S; Nii, M; Tanaka, H; Tanaka, K | 1 |
| Derderian, SC; Etemadi, M; Fineman, JR; Gong, W; Iqbal, C; Johengen, M; Miniati, D; Oishi, P; Schecter, SC; Shue, EH | 1 |
| Cleary, KL; Običan, SG | 1 |
| Ikeda, T; Kamimoto, Y; Kubo, M; Murabayashi, N; Nii, M; Osato, K; Sakamoto, M; Tanaka, H; Umekawa, T | 1 |
| Ikeda, T; Kamimoto, Y; Kubo, M; Maekawa, Y; Murabayashi, N; Nii, M; Osato, K; Tanaka, H; Umekawa, T | 1 |
| Akdag, E; Akyol, M; Haberal, A; Kayir, H; Kucukozkan, T; Oter, S; Ozdegirmenci, O; Topal, T; Uzbay, T | 1 |
| Baek, SB; Bahn, G; Kim, BK; Kim, CJ; Kim, KH; Kim, SE; Kim, TS; Ko, IG; Lee, J; Moon, SJ; Shin, MS; Sung, YH | 1 |
3 review(s) available for tadalafil and Pregnancy
| Article | Year |
|---|---|
Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.
Topics: Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Distress; Fetal Growth Retardation; Humans; Hypertension, Pulmonary; Infant, Newborn; Phosphodiesterase 5 Inhibitors; Pregnancy; Sildenafil Citrate; Tadalafil | 2022 |
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
Topics: Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Nitric Oxide; Nitroglycerin; Placenta; Pregnancy; Premature Birth; Sildenafil Citrate; Tadalafil | 2023 |
Pulmonary arterial hypertension in pregnancy.
Topics: Anesthesia, Obstetrical; Bosentan; Carbolines; Directive Counseling; Epoprostenol; Extracorporeal Membrane Oxygenation; Familial Primary Pulmonary Hypertension; Female; Humans; Iloprost; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Pulmonary Circulation; Purines; Sildenafil Citrate; Sulfonamides; Tadalafil | 2014 |
6 trial(s) available for tadalafil and Pregnancy
| Article | Year |
|---|---|
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).
Topics: Clinical Trials, Phase II as Topic; Double-Blind Method; Female; Fetal Growth Retardation; Fetus; Gestational Age; Humans; Infant, Newborn; Multicenter Studies as Topic; Pregnancy; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome | 2022 |
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial.
Topics: Female; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2021 |
Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study.
Topics: Adult; Female; Fetal Death; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pregnancy; Premature Birth; Tadalafil | 2017 |
Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease.
Topics: Adult; Female; Fetal Growth Retardation; Heart; Humans; Pregnancy; Tadalafil; Vasodilator Agents | 2019 |
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
Topics: Clinical Trials, Phase II as Topic; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Japan; Multicenter Studies as Topic; Perinatal Mortality; Phosphodiesterase 5 Inhibitors; Pregnancy; Prenatal Care; Prospective Studies; Randomized Controlled Trials as Topic; Tadalafil; Ultrasonography, Doppler | 2018 |
Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy.
Topics: Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Pregnancy; Pregnancy, Twin; Tadalafil; Twins, Monozygotic | 2021 |
19 other study(ies) available for tadalafil and Pregnancy
| Article | Year |
|---|---|
Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling.
Topics: Animals; Female; Fetal Growth Retardation; Mice; NG-Nitroarginine Methyl Ester; Placenta; Pre-Eclampsia; Pregnancy; Signal Transduction; Tadalafil; TOR Serine-Threonine Kinases | 2022 |
Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women.
Topics: Female; Fetal Growth Retardation; Humans; Placental Circulation; Pregnancy; Pregnant Women; Tadalafil | 2022 |
Parental exposure of Tadalafil has beneficial effect on reflexive motor behaviors in mice offspring.
Topics: Animals; Antidepressive Agents; Antioxidants; Female; Glutathione Peroxidase; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Superoxide Dismutase; Tadalafil | 2022 |
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction.
Topics: Biometry; Child; Female; Fetal Growth Retardation; Humans; Infant; Infant, Newborn; Pregnancy; Prognosis; Retrospective Studies; Tadalafil; Ultrasonography, Prenatal | 2023 |
Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Fetal Growth Retardation; Hypertension; Male; Mice; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2020 |
Effect and mechanism of prophylactic use of tadalafil during pregnancy on l-NAME-induced preeclampsia-like rats.
Topics: Animals; Blood Pressure; Cytokines; Female; Femoral Artery; Kidney; NG-Nitroarginine Methyl Ester; Phosphodiesterase 5 Inhibitors; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Tadalafil; Ultrasonography | 2020 |
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction.
Topics: Female; Fetal Growth Retardation; Humans; Hypoxia; Pregnancy; Sirolimus; Tadalafil; TOR Serine-Threonine Kinases | 2020 |
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring.
Topics: Adipocytes; Animals; Diet, High-Fat; Female; Fetal Development; Fetal Growth Retardation; Glucose Tolerance Test; Hypertension; Hypertrophy; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Pregnancy; Prenatal Exposure Delayed Effects; Tadalafil | 2021 |
Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction.
Topics: Adult; Female; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2017 |
Mechanisms and Treatment of Halogen Inhalation-Induced Pulmonary and Systemic Injuries in Pregnant Mice.
Topics: Animals; Bromine; Disease Models, Animal; Female; Fetal Growth Retardation; Hypertension; Inhalation Exposure; Lung Injury; Mice; Oxidants; Phosphodiesterase 5 Inhibitors; Placenta; Pre-Eclampsia; Pregnancy; Systemic Inflammatory Response Syndrome; Tadalafil; Treatment Outcome | 2017 |
Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
Topics: Animals; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Female; Fetal Development; Fetal Growth Retardation; Kidney; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Placenta; Pre-Eclampsia; Pregnancy; Proteinuria; Tadalafil | 2017 |
Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
Topics: Arteries; Female; Fetal Growth Retardation; Humans; Perfusion; Phosphodiesterase 5 Inhibitors; Placenta; Pregnancy; Sildenafil Citrate; Tadalafil; Vasoconstriction | 2018 |
Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Disease Models, Animal; Female; Fetal Growth Retardation; Hypoxia; Mice; Placenta; Pre-Eclampsia; Pregnancy; Tadalafil; Treatment Outcome; Vasodilator Agents | 2019 |
Oxidative stress assessment in intestine of newborn rats submitted to hypoxia and reoxygenation with tadalafil.
Topics: Animals; Animals, Newborn; Female; Humans; Hypoxia; Intestinal Mucosa; Lipid Peroxidation; Malondialdehyde; Nitrates; Nitrites; Oxidative Stress; Oxygen; Phosphodiesterase 5 Inhibitors; Pregnancy; Random Allocation; Rats, Wistar; Reproducibility of Results; Tadalafil; Time Factors | 2019 |
Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia.
Topics: Animals; Carbolines; Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Induction; Female; Fetal Diseases; Fetal Therapies; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Maternal-Fetal Exchange; Nitric Oxide Synthase Type III; Organ Size; Phosphodiesterase 5 Inhibitors; Pregnancy; Random Allocation; Second Messenger Systems; Sheep; Tadalafil | 2014 |
Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report.
Topics: Adult; Asian People; Cesarean Section; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Male; Oligohydramnios; Phosphodiesterase 5 Inhibitors; Pregnancy; Pregnancy Outcome; Tadalafil; Ultrasonography, Prenatal | 2016 |
Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes.
Topics: Adult; Birth Weight; Delivery, Obstetric; Female; Fetal Growth Retardation; Humans; Outcome Assessment, Health Care; Phosphodiesterase 5 Inhibitors; Pregnancy; Retrospective Studies; Tadalafil | 2017 |
Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain.
Topics: Animals; Brain; Carbolines; Female; Fetus; Glutathione Peroxidase; Malondialdehyde; Piperazines; Pregnancy; Purines; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Sildenafil Citrate; Sulfones; Superoxide Dismutase; Tadalafil; Vasodilator Agents | 2011 |
The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pups.
Topics: Age Factors; Animals; Animals, Newborn; Apoptosis; Avoidance Learning; Bromodeoxyuridine; Carbolines; Caspase 3; Cell Proliferation; Dentate Gyrus; Depression; Disease Models, Animal; DNA Fragmentation; Female; Freezing Reaction, Cataleptic; In Situ Nick-End Labeling; Maternal Deprivation; Memory Disorders; Phosphodiesterase 5 Inhibitors; Pregnancy; Rats; Rats, Sprague-Dawley; Reaction Time; Swimming; Tadalafil | 2011 |